CID 16130388

(3-5)octadecylamide conjugated oligonucleotide (p-ctccgcttct)

Structural Information

Molecular Formula
C113H163N29O64P10
SMILES
CCCCCCCCCCCCCCCCCCNP(=O)(O)OCC1C(CC(O1)N2C=CC(=NC2=O)N)OP(=O)(O)OCC3C(CC(O3)N4C=C(C(=O)NC4=O)C)OP(=O)(O)OCC5C(CC(O5)N6C=CC(=NC6=O)N)OP(=O)(O)OCC7C(CC(O7)N8C=CC(=NC8=O)N)OP(=O)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)O
InChI
InChI=1S/C113H163N29O64P10/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27-121-207(158,159)178-48-73-63(34-88(189-73)133-28-22-82(114)122-105(133)149)198-209(162,163)184-53-78-68(39-93(194-78)139-44-59(3)100(145)130-111(139)155)203-214(172,173)182-51-76-65(36-90(192-76)135-30-24-84(116)124-107(135)151)200-210(164,165)180-50-75-67(38-92(191-75)137-32-26-86(118)126-109(137)153)202-212(168,169)187-56-81-71(42-96(197-81)142-57-120-97-98(142)127-104(119)128-103(97)148)206-216(176,177)183-52-77-66(37-91(193-77)136-31-25-85(117)125-108(136)152)201-211(166,167)185-54-79-70(41-95(195-79)141-46-61(5)102(147)132-113(141)157)205-215(174,175)186-55-80-69(40-94(196-80)140-45-60(4)101(146)131-112(140)156)204-213(170,171)181-49-74-64(35-89(190-74)134-29-23-83(115)123-106(134)150)199-208(160,161)179-47-72-62(143)33-87(188-72)138-43-58(2)99(144)129-110(138)154/h22-26,28-32,43-46,57,62-81,87-96,143H,6-21,27,33-42,47-56H2,1-5H3,(H,160,161)(H,162,163)(H,164,165)(H,166,167)(H,168,169)(H,170,171)(H,172,173)(H,174,175)(H,176,177)(H2,114,122,149)(H2,115,123,150)(H2,116,124,151)(H2,117,125,152)(H2,118,126,153)(H2,121,158,159)(H,129,144,154)(H,130,145,155)(H,131,146,156)(H,132,147,157)(H3,119,127,128,148)
InChIKey
SMAIPEYJDZZLPJ-UHFFFAOYSA-N
Compound name
[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[[3-[[3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-N-octadecylphosphonamidic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3259.7769 Da
Monoisotopic Mass

-12.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3260.7842 293.7
[M+Na]+ 3282.7661 299.7
[M-H]- 3258.7696 297.6
[M+NH4]+ 3277.8107 296.1
[M+K]+ 3298.7401 295.6
[M+H-H2O]+ 3242.7742 292.0
[M+HCOO]- 3304.7751 296.1
[M+CH3COO]- 3318.7908 296.5
[M+Na-2H]- 3280.7516 306.6
[M]+ 3259.7764 293.1
[M]- 3259.7774 293.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.